{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:04:04Z","timestamp":1790643844692,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.path.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:12:39Z","timestamp":1558609959000},"page":"849-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Castleman Disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2019.03.003_bib1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymph node hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"key":"10.1016\/j.path.2019.03.003_bib2","first-page":"1001","article-title":"Case records of the Massachusetts General Hospital: case no. 40231","volume":"250","author":"Castleman","year":"1954","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2019.03.003_bib3","first-page":"119","article-title":"Benign giant lymphoma: the clinical signs and symptoms and the morphological aspects","volume":"12","author":"Flendrig","year":"1969","journal-title":"Folia Med"},{"key":"10.1016\/j.path.2019.03.003_bib4","first-page":"525","article-title":"Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis","volume":"5","author":"Menke","year":"1992","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","article-title":"Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations","volume":"29","author":"Keller","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.path.2019.03.003_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ajcp\/69.1.86","article-title":"Multicentric giant lymph node hyperplasia","volume":"69","author":"Gaba","year":"1978","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00000478-198304000-00001","article-title":"A\u00a0systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease. Pathological findings in 15 patients","volume":"7","author":"Frizzera","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.hoc.2017.09.002","article-title":"Castleman disease pathogenesis","volume":"32","author":"Fajgenbaum","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.path.2019.03.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2017.09.001","article-title":"Epidemiology of Castleman disease","volume":"32","author":"Simpson","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.path.2019.03.003_bib10","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2016-11-748855","article-title":"Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease","volume":"129","author":"Yu","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.003_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hoc.2017.09.006","article-title":"Unicentric Castleman disease","volume":"32","author":"Wong","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.path.2019.03.003_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/SLA.0b013e318249dcdc","article-title":"Surgery in Castleman\u2019s disease: a systematic review of 404 published cases","volume":"255","author":"Talat","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.path.2019.03.003_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.15019","article-title":"The full spectrum of Castleman disease: 273 patients studied over 20 years","volume":"180","author":"Oksenhendler","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2019.03.003_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01607150","article-title":"Morpho-immunophenotypic diversity of Castleman\u2019s disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis","volume":"423","author":"Danon","year":"1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.path.2019.03.003_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-2002-19840","article-title":"A\u00a0case of Castleman\u2019s disease with \"downhill\" varices in the absence of superior vena cava obstruction","volume":"34","author":"Serin","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.path.2019.03.003_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(04)15539-6","article-title":"Castleman's tumours and production of autoantibody in paraneoplastic pemphigus","volume":"363","author":"Wang","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.path.2019.03.003_bib17","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0003-4975(02)04963-9","article-title":"Castleman's disease associated with myasthenia gravis","volume":"75","author":"Day","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.path.2019.03.003_bib18","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman\u2019s disease: a systematic literature review","volume":"3","author":"Liu","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.path.2019.03.003_bib19","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.003_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1096-911X(199601)26:1<48::AID-MPO6>3.0.CO;2-V","article-title":"Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman\u2019s disease","volume":"26","author":"Winter","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.path.2019.03.003_bib21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(96)07560-5","article-title":"Prevalence of Kaposi\u2019s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen","volume":"348","author":"Simpson","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.path.2019.03.003_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hoc.2017.09.009","article-title":"TAFRO syndrome","volume":"32","author":"Igawa","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.path.2019.03.003_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.path.2019.03.003_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3960\/jslrt.53.69","article-title":"Clinical features and treatment of multicentric Castleman\u2019s disease : a retrospective study of 21 Japanese patients at a single institute","volume":"53","author":"Kawabata","year":"2013","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.path.2019.03.003_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature","volume":"59","author":"Bardwick","year":"1980","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.path.2019.03.003_bib26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajh.24802","article-title":"Poems syndrome: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.path.2019.03.003_bib27","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00000478-199011000-00005","article-title":"Glomeruloid hemangioma. A distinctive cutaneous lesion of multicentric Castleman\u2019s disease associated with poems syndrome","volume":"14","author":"Chan","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00000478-200006000-00016","article-title":"A\u00a0chromosomal abnormality in hyaline vascular Castleman\u2019s disease: evidence for clonal proliferation of dysplastic stromal cells","volume":"24","author":"Pauwels","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00000478-200205000-00013","article-title":"Hyaline vascular Castleman\u2019s disease with hmgic rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis","volume":"26","author":"Cokelaere","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/modpathol.2013.202","article-title":"Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease","volume":"27","author":"Chang","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2559.1991.tb01500.x","article-title":"Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman\u2019s disease): evidence for dysplasia of follicular dendritic reticulum cells","volume":"19","author":"Ruco","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.03.003_bib32","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069.h8002069_2069_2073","article-title":"High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients","volume":"96","author":"Oksenhendler","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.003_bib33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0046-8177(93)90132-Z","article-title":"Expression of interleukin-6 in Castleman\u2019s disease","volume":"24","author":"Hsu","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s002770050224","article-title":"Interleukin-6 receptor expression in the peripheral B cells of patients with multicentric Castleman\u2019s disease","volume":"73","author":"Ishiyama","year":"1996","journal-title":"Ann Hematol"},{"key":"10.1016\/j.path.2019.03.003_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1016\/j.path.2019.03.003_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood.V85.2.487.487","article-title":"Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis","volume":"85","author":"Kawano","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.003_bib37","first-page":"150","article-title":"Involvement of human interleukin-6 in systemic manifestations of human herpesvirus type 8-associated multicentric Castleman\u2019s disease","volume":"13","author":"Foussat","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.path.2019.03.003_bib38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1172\/JCI114749","article-title":"Dysregulated interleukin 6 expression produces a syndrome resembling Castleman\u2019s disease in mice","volume":"86","author":"Brandt","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.path.2019.03.003_bib39","first-page":"346","article-title":"Castleman's disease and related disorders","volume":"5","author":"Frizzera","year":"1988","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002030-199601000-00009","article-title":"Multicentric Castleman\u2019s disease in HIV infection: a clinical and pathological study of 20 patients","volume":"10","author":"Oksenhendler","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.path.2019.03.003_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.med.52.1.453","article-title":"Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus","volume":"52","author":"Boshoff","year":"2001","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.path.2019.03.003_bib42","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0198-8859(99)00083-X","article-title":"KSHV-encoded viral il-6 activates multiple human il-6 signaling pathways","volume":"60","author":"Osborne","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.path.2019.03.003_bib43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/593567","article-title":"Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman\u2019s disease are associated with a high increase in Kaposi\u2019s sarcoma herpesvirus DNA load in peripheral blood mononuclear cells","volume":"175","author":"Grandadam","year":"1997","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.path.2019.03.003_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/pin.12446","article-title":"Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty","volume":"66","author":"Medina","year":"2016","journal-title":"Pathol Int"},{"key":"10.1016\/j.path.2019.03.003_bib45","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00000478-199711000-00004","article-title":"Angiomyoid and follicular dendritic cell proliferative lesions in Castleman\u2019s disease of hyaline-vascular type: a study of 10 cases","volume":"21","author":"Lin","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00000478-200301000-00010","article-title":"Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman\u2019s disease","volume":"27","author":"Amin","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib47","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.96.8.4546","article-title":"Distribution of human herpesvirus-8 latently infected cells in Kaposi\u2019s sarcoma, multicentric Castleman\u2019s disease, and primary effusion lymphoma","volume":"96","author":"Dupin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.path.2019.03.003_bib48","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/his.12213","article-title":"Increased cd5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall","volume":"63","author":"Liu","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.03.003_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/hupa.2001.21131","article-title":"Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi\u2019s sarcoma and lymphoid cells of multicentric Castleman\u2019s disease","volume":"32","author":"Brousset","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/viro.2000.0196","article-title":"Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi\u2019s sarcoma, and multicentric Castleman\u2019s disease","volume":"269","author":"Katano","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.path.2019.03.003_bib51","first-page":"84","article-title":"Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman\u2019s disease. Association with Epstein Barr virus","volume":"131","author":"Hanson","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib52","doi-asserted-by":"crossref","first-page":"e1006967","DOI":"10.1371\/journal.ppat.1006967","article-title":"Kshv induces immunoglobulin rearrangements in mature b lymphocytes","volume":"14","author":"Totonchy","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.path.2019.03.003_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2559.1989.tb02162.x","article-title":"An immunohistological and genotypic study of the plasma cell form of Castleman\u2019s disease","volume":"14","author":"Hall","year":"1989","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.03.003_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2559.1989.tb02110.x","article-title":"Monoclonality and polyclonality of plasma cells in Castleman\u2019s disease of the plasma cell variant","volume":"14","author":"Radaszkiewicz","year":"1989","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.03.003_bib55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2559.2005.02319.x","article-title":"Immunoglobulin and T-cell receptor gene rearrangement in Castleman\u2019s disease: molecular genetic analysis","volume":"48","author":"Al-Maghrabi","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.03.003_bib56","first-page":"212","article-title":"Chromosomal abnormalities in Castleman\u2019s disease with high levels of serum interleukin-6","volume":"34","author":"Nakamura","year":"1993","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.path.2019.03.003_bib57","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V86.3.1131.1131","article-title":"Molecular analysis of clonality in Castleman\u2019s disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.003_bib58","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q","article-title":"Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy","volume":"92","author":"Chronowski","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.path.2019.03.003_bib59","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/1078-0432.CCR-14-1678","article-title":"FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease","volume":"21","author":"Deisseroth","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2019.03.003_bib60","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1182\/blood-2010-03-271791","article-title":"Down-regulation of hepcidin resulting from long-term treatment with an anti-il-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease","volume":"116","author":"Song","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.003_bib61","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","volume":"132","author":"van Rhee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.003_bib62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00000478-199405000-00013","article-title":"Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman\u2019s disease","volume":"18","author":"Chan","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib63","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1365-2559.2001.01134.x","article-title":"Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman\u2019s disease of the nasopharynx: tracing its evolution by sequential biopsies","volume":"38","author":"Chan","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.03.003_bib64","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00000478-199007000-00001","article-title":"Development of vascular neoplasia in Castleman\u2019s disease. Report of seven cases","volume":"14","author":"Gerald","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib65","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/PAS.0b013e318264e223","article-title":"Tdt+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma","volume":"36","author":"Ohgami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib66","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pathol.2017.09.017","article-title":"Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease","volume":"50","author":"Quesada","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.path.2019.03.003_bib67","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1096-9896(200102)193:2<200::AID-PATH773>3.0.CO;2-L","article-title":"Primary effusion lymphoma in HIV-infected patients with multicentric Castleman\u2019s disease","volume":"193","author":"Ascoli","year":"2001","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ajh.10022","article-title":"Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review","volume":"69","author":"Larroche","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.path.2019.03.003_bib69","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopha.2006.09.004","article-title":"Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients","volume":"60","author":"Kojima","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.path.2019.03.003_bib70","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0344-0338(97)80015-5","article-title":"Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman' disease: a clinicopathologic study of five cases","volume":"193","author":"Kojima","year":"1997","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.path.2019.03.003_bib71","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/modpathol.2009.17","article-title":"Systemic igg4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman\u2019s disease","volume":"22","author":"Sato","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.03.003_bib72","first-page":"270","article-title":"Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases","volume":"118","author":"Zarate-Osorno","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2019.03.003_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2559.1991.tb00833.x","article-title":"Hodgkin's disease presenting with the histological features of Castleman\u2019s disease","volume":"18","author":"Maheswaran","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.03.003_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.humpath.2017.08.024","article-title":"Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature","volume":"68","author":"Pina-Oviedo","year":"2017","journal-title":"Hum Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:40:00Z","timestamp":1761748800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1875918119300200"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.03.003","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Castleman Disease","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}